nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Pharyngitis—Temozolomide—melanoma	0.00113	0.00209	CcSEcCtD
Goserelin—Chills—Dactinomycin—melanoma	0.00113	0.00209	CcSEcCtD
Goserelin—Urinary tract disorder—Temozolomide—melanoma	0.00113	0.00208	CcSEcCtD
Goserelin—Oedema peripheral—Temozolomide—melanoma	0.00112	0.00207	CcSEcCtD
Goserelin—Cardiac failure—Docetaxel—melanoma	0.00112	0.00207	CcSEcCtD
Goserelin—Pruritus—Vemurafenib—melanoma	0.00112	0.00207	CcSEcCtD
Goserelin—Lethargy—Docetaxel—melanoma	0.00112	0.00207	CcSEcCtD
Goserelin—Urethral disorder—Temozolomide—melanoma	0.00112	0.00206	CcSEcCtD
Goserelin—Alopecia—Dactinomycin—melanoma	0.00111	0.00206	CcSEcCtD
Goserelin—Eye disorder—Carmustine—melanoma	0.0011	0.00204	CcSEcCtD
Goserelin—Erythema—Dactinomycin—melanoma	0.0011	0.00203	CcSEcCtD
Goserelin—Ill-defined disorder—Bleomycin—melanoma	0.00109	0.00202	CcSEcCtD
Goserelin—Anaemia—Bleomycin—melanoma	0.00109	0.00201	CcSEcCtD
Goserelin—Diarrhoea—Vemurafenib—melanoma	0.00108	0.002	CcSEcCtD
Goserelin—Migraine—Docetaxel—melanoma	0.00108	0.00199	CcSEcCtD
Goserelin—Eye disorder—Temozolomide—melanoma	0.00106	0.00197	CcSEcCtD
Goserelin—Malaise—Bleomycin—melanoma	0.00106	0.00196	CcSEcCtD
Goserelin—Cardiac disorder—Temozolomide—melanoma	0.00106	0.00195	CcSEcCtD
Goserelin—Arrhythmia—Carmustine—melanoma	0.00105	0.00195	CcSEcCtD
Goserelin—Leukopenia—Bleomycin—melanoma	0.00105	0.00195	CcSEcCtD
Goserelin—Dizziness—Vemurafenib—melanoma	0.00105	0.00194	CcSEcCtD
Goserelin—Alopecia—Carmustine—melanoma	0.00104	0.00193	CcSEcCtD
Goserelin—Angiopathy—Temozolomide—melanoma	0.00103	0.00191	CcSEcCtD
Goserelin—Mental disorder—Carmustine—melanoma	0.00103	0.00191	CcSEcCtD
Goserelin—Immune system disorder—Temozolomide—melanoma	0.00103	0.0019	CcSEcCtD
Goserelin—Malnutrition—Carmustine—melanoma	0.00103	0.0019	CcSEcCtD
Goserelin—Erythema—Carmustine—melanoma	0.00103	0.0019	CcSEcCtD
Goserelin—Cough—Bleomycin—melanoma	0.00103	0.0019	CcSEcCtD
Goserelin—Chills—Temozolomide—melanoma	0.00102	0.00189	CcSEcCtD
Goserelin—Ill-defined disorder—Dactinomycin—melanoma	0.00102	0.00188	CcSEcCtD
Goserelin—Anaemia—Dactinomycin—melanoma	0.00101	0.00187	CcSEcCtD
Goserelin—Vomiting—Vemurafenib—melanoma	0.00101	0.00186	CcSEcCtD
Goserelin—Alopecia—Temozolomide—melanoma	0.00101	0.00186	CcSEcCtD
Goserelin—Dry skin—Docetaxel—melanoma	0.001	0.00186	CcSEcCtD
Goserelin—Chest pain—Bleomycin—melanoma	0.001	0.00185	CcSEcCtD
Goserelin—Myalgia—Bleomycin—melanoma	0.001	0.00185	CcSEcCtD
Goserelin—Rash—Vemurafenib—melanoma	0.000999	0.00185	CcSEcCtD
Goserelin—Mental disorder—Temozolomide—melanoma	0.000998	0.00185	CcSEcCtD
Goserelin—Dermatitis—Vemurafenib—melanoma	0.000998	0.00184	CcSEcCtD
Goserelin—Back pain—Carmustine—melanoma	0.000993	0.00184	CcSEcCtD
Goserelin—Headache—Vemurafenib—melanoma	0.000992	0.00183	CcSEcCtD
Goserelin—Erythema—Temozolomide—melanoma	0.000992	0.00183	CcSEcCtD
Goserelin—Malnutrition—Temozolomide—melanoma	0.000992	0.00183	CcSEcCtD
Goserelin—Breast disorder—Docetaxel—melanoma	0.00099	0.00183	CcSEcCtD
Goserelin—Discomfort—Bleomycin—melanoma	0.000989	0.00183	CcSEcCtD
Goserelin—Malaise—Dactinomycin—melanoma	0.000989	0.00183	CcSEcCtD
Goserelin—Leukopenia—Dactinomycin—melanoma	0.000982	0.00181	CcSEcCtD
Goserelin—Confusional state—Bleomycin—melanoma	0.000968	0.00179	CcSEcCtD
Goserelin—Vision blurred—Carmustine—melanoma	0.000967	0.00179	CcSEcCtD
Goserelin—Anaphylactic shock—Bleomycin—melanoma	0.00096	0.00177	CcSEcCtD
Goserelin—Oedema—Bleomycin—melanoma	0.00096	0.00177	CcSEcCtD
Goserelin—Back pain—Temozolomide—melanoma	0.00096	0.00177	CcSEcCtD
Goserelin—Infection—Bleomycin—melanoma	0.000953	0.00176	CcSEcCtD
Goserelin—Anaemia—Carmustine—melanoma	0.000949	0.00175	CcSEcCtD
Goserelin—Nausea—Vemurafenib—melanoma	0.000941	0.00174	CcSEcCtD
Goserelin—Thrombocytopenia—Bleomycin—melanoma	0.00094	0.00174	CcSEcCtD
Goserelin—Vision blurred—Temozolomide—melanoma	0.000935	0.00173	CcSEcCtD
Goserelin—Myalgia—Dactinomycin—melanoma	0.000934	0.00173	CcSEcCtD
Goserelin—Discomfort—Dactinomycin—melanoma	0.000923	0.0017	CcSEcCtD
Goserelin—Angina pectoris—Docetaxel—melanoma	0.000922	0.0017	CcSEcCtD
Goserelin—Ill-defined disorder—Temozolomide—melanoma	0.00092	0.0017	CcSEcCtD
Goserelin—Leukopenia—Carmustine—melanoma	0.000919	0.0017	CcSEcCtD
Goserelin—Anaemia—Temozolomide—melanoma	0.000917	0.00169	CcSEcCtD
Goserelin—Anorexia—Bleomycin—melanoma	0.000915	0.00169	CcSEcCtD
Goserelin—Hypotension—Bleomycin—melanoma	0.000897	0.00166	CcSEcCtD
Goserelin—Oedema—Dactinomycin—melanoma	0.000895	0.00165	CcSEcCtD
Goserelin—Malaise—Temozolomide—melanoma	0.000895	0.00165	CcSEcCtD
Goserelin—Convulsion—Carmustine—melanoma	0.000889	0.00164	CcSEcCtD
Goserelin—Infection—Dactinomycin—melanoma	0.000889	0.00164	CcSEcCtD
Goserelin—Leukopenia—Temozolomide—melanoma	0.000888	0.00164	CcSEcCtD
Goserelin—Hypertension—Carmustine—melanoma	0.000886	0.00164	CcSEcCtD
Goserelin—Palpitations—Temozolomide—melanoma	0.000877	0.00162	CcSEcCtD
Goserelin—Thrombocytopenia—Dactinomycin—melanoma	0.000876	0.00162	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000874	0.00162	CcSEcCtD
Goserelin—Myalgia—Carmustine—melanoma	0.000874	0.00162	CcSEcCtD
Goserelin—Chest pain—Carmustine—melanoma	0.000874	0.00162	CcSEcCtD
Goserelin—Anxiety—Carmustine—melanoma	0.000871	0.00161	CcSEcCtD
Goserelin—Cough—Temozolomide—melanoma	0.000866	0.0016	CcSEcCtD
Goserelin—Paraesthesia—Bleomycin—melanoma	0.000862	0.00159	CcSEcCtD
Goserelin—Weight increased—Docetaxel—melanoma	0.000862	0.00159	CcSEcCtD
Goserelin—Convulsion—Temozolomide—melanoma	0.000859	0.00159	CcSEcCtD
Goserelin—Hypertension—Temozolomide—melanoma	0.000856	0.00158	CcSEcCtD
Goserelin—Dyspnoea—Bleomycin—melanoma	0.000856	0.00158	CcSEcCtD
Goserelin—Anorexia—Dactinomycin—melanoma	0.000853	0.00158	CcSEcCtD
Goserelin—Pneumonia—Docetaxel—melanoma	0.000849	0.00157	CcSEcCtD
Goserelin—Confusional state—Carmustine—melanoma	0.000845	0.00156	CcSEcCtD
Goserelin—Arthralgia—Temozolomide—melanoma	0.000845	0.00156	CcSEcCtD
Goserelin—Myalgia—Temozolomide—melanoma	0.000845	0.00156	CcSEcCtD
Goserelin—Anxiety—Temozolomide—melanoma	0.000842	0.00156	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000839	0.00155	CcSEcCtD
Goserelin—Oedema—Carmustine—melanoma	0.000838	0.00155	CcSEcCtD
Goserelin—Discomfort—Temozolomide—melanoma	0.000834	0.00154	CcSEcCtD
Goserelin—Decreased appetite—Bleomycin—melanoma	0.000834	0.00154	CcSEcCtD
Goserelin—Infection—Carmustine—melanoma	0.000832	0.00154	CcSEcCtD
Goserelin—Acute coronary syndrome—Docetaxel—melanoma	0.000832	0.00154	CcSEcCtD
Goserelin—Renal failure—Docetaxel—melanoma	0.00083	0.00153	CcSEcCtD
Goserelin—Myocardial infarction—Docetaxel—melanoma	0.000827	0.00153	CcSEcCtD
Goserelin—Dry mouth—Temozolomide—melanoma	0.000826	0.00153	CcSEcCtD
Goserelin—Jaundice—Docetaxel—melanoma	0.000823	0.00152	CcSEcCtD
Goserelin—Pain—Bleomycin—melanoma	0.000821	0.00152	CcSEcCtD
Goserelin—Thrombocytopenia—Carmustine—melanoma	0.00082	0.00152	CcSEcCtD
Goserelin—Tachycardia—Carmustine—melanoma	0.000818	0.00151	CcSEcCtD
Goserelin—Confusional state—Temozolomide—melanoma	0.000816	0.00151	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000816	0.00151	CcSEcCtD
Goserelin—Anaphylactic shock—Temozolomide—melanoma	0.00081	0.0015	CcSEcCtD
Goserelin—Oedema—Temozolomide—melanoma	0.00081	0.0015	CcSEcCtD
Goserelin—Infection—Temozolomide—melanoma	0.000804	0.00149	CcSEcCtD
Goserelin—Anorexia—Carmustine—melanoma	0.000799	0.00148	CcSEcCtD
Goserelin—Epistaxis—Docetaxel—melanoma	0.000796	0.00147	CcSEcCtD
Goserelin—Nervous system disorder—Temozolomide—melanoma	0.000794	0.00147	CcSEcCtD
Goserelin—Thrombocytopenia—Temozolomide—melanoma	0.000793	0.00146	CcSEcCtD
Goserelin—Feeling abnormal—Bleomycin—melanoma	0.000791	0.00146	CcSEcCtD
Goserelin—Skin disorder—Temozolomide—melanoma	0.000786	0.00145	CcSEcCtD
Goserelin—Hypotension—Carmustine—melanoma	0.000783	0.00145	CcSEcCtD
Goserelin—Hyperhidrosis—Temozolomide—melanoma	0.000783	0.00145	CcSEcCtD
Goserelin—Decreased appetite—Dactinomycin—melanoma	0.000778	0.00144	CcSEcCtD
Goserelin—Fatigue—Dactinomycin—melanoma	0.000772	0.00143	CcSEcCtD
Goserelin—Anorexia—Temozolomide—melanoma	0.000772	0.00143	CcSEcCtD
Goserelin—Pain—Dactinomycin—melanoma	0.000765	0.00141	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Carmustine—melanoma	0.000763	0.00141	CcSEcCtD
Goserelin—Urticaria—Bleomycin—melanoma	0.000762	0.00141	CcSEcCtD
Goserelin—Haemoglobin—Docetaxel—melanoma	0.000762	0.00141	CcSEcCtD
Goserelin—Rhinitis—Docetaxel—melanoma	0.00076	0.0014	CcSEcCtD
Goserelin—Body temperature increased—Bleomycin—melanoma	0.000759	0.0014	CcSEcCtD
Goserelin—Haemorrhage—Docetaxel—melanoma	0.000758	0.0014	CcSEcCtD
Goserelin—Hepatitis—Docetaxel—melanoma	0.000758	0.0014	CcSEcCtD
Goserelin—Insomnia—Carmustine—melanoma	0.000758	0.0014	CcSEcCtD
Goserelin—Paraesthesia—Carmustine—melanoma	0.000752	0.00139	CcSEcCtD
Goserelin—Pharyngitis—Docetaxel—melanoma	0.000752	0.00139	CcSEcCtD
Goserelin—Urinary tract disorder—Docetaxel—melanoma	0.000748	0.00138	CcSEcCtD
Goserelin—Dyspnoea—Carmustine—melanoma	0.000747	0.00138	CcSEcCtD
Goserelin—Oedema peripheral—Docetaxel—melanoma	0.000747	0.00138	CcSEcCtD
Goserelin—Somnolence—Carmustine—melanoma	0.000745	0.00138	CcSEcCtD
Goserelin—Urethral disorder—Docetaxel—melanoma	0.000743	0.00137	CcSEcCtD
Goserelin—Feeling abnormal—Dactinomycin—melanoma	0.000738	0.00136	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000738	0.00136	CcSEcCtD
Goserelin—Insomnia—Temozolomide—melanoma	0.000732	0.00135	CcSEcCtD
Goserelin—Gastrointestinal pain—Dactinomycin—melanoma	0.000732	0.00135	CcSEcCtD
Goserelin—Decreased appetite—Carmustine—melanoma	0.000728	0.00135	CcSEcCtD
Goserelin—Paraesthesia—Temozolomide—melanoma	0.000727	0.00134	CcSEcCtD
Goserelin—Dyspnoea—Temozolomide—melanoma	0.000722	0.00133	CcSEcCtD
Goserelin—Somnolence—Temozolomide—melanoma	0.00072	0.00133	CcSEcCtD
Goserelin—Pain—Carmustine—melanoma	0.000716	0.00132	CcSEcCtD
Goserelin—Constipation—Carmustine—melanoma	0.000716	0.00132	CcSEcCtD
Goserelin—Dyspepsia—Temozolomide—melanoma	0.000713	0.00132	CcSEcCtD
Goserelin—Eye disorder—Docetaxel—melanoma	0.000708	0.00131	CcSEcCtD
Goserelin—Body temperature increased—Dactinomycin—melanoma	0.000708	0.00131	CcSEcCtD
Goserelin—Abdominal pain—Dactinomycin—melanoma	0.000708	0.00131	CcSEcCtD
Goserelin—Hypersensitivity—Bleomycin—melanoma	0.000707	0.00131	CcSEcCtD
Goserelin—Decreased appetite—Temozolomide—melanoma	0.000704	0.0013	CcSEcCtD
Goserelin—Cardiac disorder—Docetaxel—melanoma	0.000703	0.0013	CcSEcCtD
Goserelin—Fatigue—Temozolomide—melanoma	0.000698	0.00129	CcSEcCtD
Goserelin—Constipation—Temozolomide—melanoma	0.000692	0.00128	CcSEcCtD
Goserelin—Pain—Temozolomide—melanoma	0.000692	0.00128	CcSEcCtD
Goserelin—Feeling abnormal—Carmustine—melanoma	0.00069	0.00128	CcSEcCtD
Goserelin—Asthenia—Bleomycin—melanoma	0.000689	0.00127	CcSEcCtD
Goserelin—Angiopathy—Docetaxel—melanoma	0.000688	0.00127	CcSEcCtD
Goserelin—Gastrointestinal pain—Carmustine—melanoma	0.000685	0.00127	CcSEcCtD
Goserelin—Immune system disorder—Docetaxel—melanoma	0.000684	0.00127	CcSEcCtD
Goserelin—Chills—Docetaxel—melanoma	0.00068	0.00126	CcSEcCtD
Goserelin—Pruritus—Bleomycin—melanoma	0.000679	0.00125	CcSEcCtD
Goserelin—Arrhythmia—Docetaxel—melanoma	0.000677	0.00125	CcSEcCtD
Goserelin—Alopecia—Docetaxel—melanoma	0.00067	0.00124	CcSEcCtD
Goserelin—Feeling abnormal—Temozolomide—melanoma	0.000667	0.00123	CcSEcCtD
Goserelin—Mental disorder—Docetaxel—melanoma	0.000664	0.00123	CcSEcCtD
Goserelin—Abdominal pain—Carmustine—melanoma	0.000662	0.00122	CcSEcCtD
Goserelin—Body temperature increased—Carmustine—melanoma	0.000662	0.00122	CcSEcCtD
Goserelin—Gastrointestinal pain—Temozolomide—melanoma	0.000662	0.00122	CcSEcCtD
Goserelin—Erythema—Docetaxel—melanoma	0.00066	0.00122	CcSEcCtD
Goserelin—Malnutrition—Docetaxel—melanoma	0.00066	0.00122	CcSEcCtD
Goserelin—Hypersensitivity—Dactinomycin—melanoma	0.000659	0.00122	CcSEcCtD
Goserelin—Urticaria—Temozolomide—melanoma	0.000643	0.00119	CcSEcCtD
Goserelin—Asthenia—Dactinomycin—melanoma	0.000642	0.00119	CcSEcCtD
Goserelin—Abdominal pain—Temozolomide—melanoma	0.00064	0.00118	CcSEcCtD
Goserelin—Body temperature increased—Temozolomide—melanoma	0.00064	0.00118	CcSEcCtD
Goserelin—Back pain—Docetaxel—melanoma	0.000638	0.00118	CcSEcCtD
Goserelin—Muscle spasms—Docetaxel—melanoma	0.000634	0.00117	CcSEcCtD
Goserelin—Hypersensitivity—Carmustine—melanoma	0.000617	0.00114	CcSEcCtD
Goserelin—Diarrhoea—Dactinomycin—melanoma	0.000612	0.00113	CcSEcCtD
Goserelin—Vomiting—Bleomycin—melanoma	0.00061	0.00113	CcSEcCtD
Goserelin—Anaemia—Docetaxel—melanoma	0.00061	0.00113	CcSEcCtD
Goserelin—Rash—Bleomycin—melanoma	0.000605	0.00112	CcSEcCtD
Goserelin—Dermatitis—Bleomycin—melanoma	0.000605	0.00112	CcSEcCtD
Goserelin—Asthenia—Carmustine—melanoma	0.000601	0.00111	CcSEcCtD
Goserelin—Hypersensitivity—Temozolomide—melanoma	0.000596	0.0011	CcSEcCtD
Goserelin—Leukopenia—Docetaxel—melanoma	0.000591	0.00109	CcSEcCtD
Goserelin—Palpitations—Docetaxel—melanoma	0.000583	0.00108	CcSEcCtD
Goserelin—Asthenia—Temozolomide—melanoma	0.000581	0.00107	CcSEcCtD
Goserelin—Cough—Docetaxel—melanoma	0.000576	0.00106	CcSEcCtD
Goserelin—Diarrhoea—Carmustine—melanoma	0.000573	0.00106	CcSEcCtD
Goserelin—Pruritus—Temozolomide—melanoma	0.000573	0.00106	CcSEcCtD
Goserelin—Convulsion—Docetaxel—melanoma	0.000572	0.00106	CcSEcCtD
Goserelin—Nausea—Bleomycin—melanoma	0.00057	0.00105	CcSEcCtD
Goserelin—Hypertension—Docetaxel—melanoma	0.00057	0.00105	CcSEcCtD
Goserelin—Vomiting—Dactinomycin—melanoma	0.000569	0.00105	CcSEcCtD
Goserelin—Rash—Dactinomycin—melanoma	0.000564	0.00104	CcSEcCtD
Goserelin—Arthralgia—Docetaxel—melanoma	0.000562	0.00104	CcSEcCtD
Goserelin—Chest pain—Docetaxel—melanoma	0.000562	0.00104	CcSEcCtD
Goserelin—Myalgia—Docetaxel—melanoma	0.000562	0.00104	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000558	0.00103	CcSEcCtD
Goserelin—Dizziness—Carmustine—melanoma	0.000554	0.00102	CcSEcCtD
Goserelin—Diarrhoea—Temozolomide—melanoma	0.000554	0.00102	CcSEcCtD
Goserelin—Dry mouth—Docetaxel—melanoma	0.000549	0.00102	CcSEcCtD
Goserelin—Confusional state—Docetaxel—melanoma	0.000543	0.001	CcSEcCtD
Goserelin—Anaphylactic shock—Docetaxel—melanoma	0.000538	0.000995	CcSEcCtD
Goserelin—Oedema—Docetaxel—melanoma	0.000538	0.000995	CcSEcCtD
Goserelin—Dizziness—Temozolomide—melanoma	0.000535	0.000989	CcSEcCtD
Goserelin—Infection—Docetaxel—melanoma	0.000535	0.000989	CcSEcCtD
Goserelin—Vomiting—Carmustine—melanoma	0.000533	0.000984	CcSEcCtD
Goserelin—Nausea—Dactinomycin—melanoma	0.000532	0.000983	CcSEcCtD
Goserelin—Shock—Docetaxel—melanoma	0.00053	0.000979	CcSEcCtD
Goserelin—Rash—Carmustine—melanoma	0.000528	0.000976	CcSEcCtD
Goserelin—Nervous system disorder—Docetaxel—melanoma	0.000528	0.000976	CcSEcCtD
Goserelin—Dermatitis—Carmustine—melanoma	0.000528	0.000975	CcSEcCtD
Goserelin—Thrombocytopenia—Docetaxel—melanoma	0.000527	0.000974	CcSEcCtD
Goserelin—Tachycardia—Docetaxel—melanoma	0.000525	0.000971	CcSEcCtD
Goserelin—Headache—Carmustine—melanoma	0.000525	0.00097	CcSEcCtD
Goserelin—Skin disorder—Docetaxel—melanoma	0.000523	0.000966	CcSEcCtD
Goserelin—Vomiting—Temozolomide—melanoma	0.000515	0.000951	CcSEcCtD
Goserelin—Anorexia—Docetaxel—melanoma	0.000513	0.000948	CcSEcCtD
Goserelin—Rash—Temozolomide—melanoma	0.00051	0.000943	CcSEcCtD
Goserelin—Dermatitis—Temozolomide—melanoma	0.00051	0.000943	CcSEcCtD
Goserelin—Headache—Temozolomide—melanoma	0.000507	0.000937	CcSEcCtD
Goserelin—Hypotension—Docetaxel—melanoma	0.000503	0.00093	CcSEcCtD
Goserelin—Nausea—Carmustine—melanoma	0.000498	0.00092	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000491	0.000907	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—AKR1B10—melanoma	0.000487	0.00106	CbGpPWpGaD
Goserelin—Insomnia—Docetaxel—melanoma	0.000487	0.0009	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—F2R—melanoma	0.000485	0.00106	CbGpPWpGaD
Goserelin—Paraesthesia—Docetaxel—melanoma	0.000483	0.000893	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—HDAC6—melanoma	0.000482	0.00105	CbGpPWpGaD
Goserelin—Nausea—Temozolomide—melanoma	0.000481	0.000889	CcSEcCtD
Goserelin—Dyspnoea—Docetaxel—melanoma	0.00048	0.000887	CcSEcCtD
Goserelin—Somnolence—Docetaxel—melanoma	0.000479	0.000885	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—EDN1—melanoma	0.000477	0.00104	CbGpPWpGaD
Goserelin—Dyspepsia—Docetaxel—melanoma	0.000474	0.000876	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—EDNRB—melanoma	0.00047	0.00102	CbGpPWpGaD
Goserelin—Decreased appetite—Docetaxel—melanoma	0.000468	0.000865	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—CSF2—melanoma	0.000467	0.00102	CbGpPWpGaD
Goserelin—Fatigue—Docetaxel—melanoma	0.000464	0.000858	CcSEcCtD
Goserelin—Constipation—Docetaxel—melanoma	0.00046	0.000851	CcSEcCtD
Goserelin—Pain—Docetaxel—melanoma	0.00046	0.000851	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CXCR2—melanoma	0.000457	0.000996	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL8—melanoma	0.000457	0.000995	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—F2RL1—melanoma	0.000453	0.000987	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RAC2—melanoma	0.00045	0.00098	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PRKCA—melanoma	0.000447	0.000975	CbGpPWpGaD
Goserelin—Feeling abnormal—Docetaxel—melanoma	0.000444	0.00082	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—GAB2—melanoma	0.000443	0.000966	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GNA11—melanoma	0.000443	0.000966	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—WNT5A—melanoma	0.000443	0.000964	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFC—melanoma	0.000443	0.000964	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—F2R—melanoma	0.00044	0.000959	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Docetaxel—melanoma	0.00044	0.000814	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—melanoma	0.000435	0.000948	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—EDN1—melanoma	0.000434	0.000945	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EDNRB—melanoma	0.000426	0.000929	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GRM3—melanoma	0.000426	0.000928	CbGpPWpGaD
Goserelin—Body temperature increased—Docetaxel—melanoma	0.000426	0.000787	CcSEcCtD
Goserelin—Abdominal pain—Docetaxel—melanoma	0.000426	0.000787	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CSF2—melanoma	0.000424	0.000923	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCR4—melanoma	0.000417	0.000908	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—melanoma	0.000417	0.000908	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—RAC1—melanoma	0.000415	0.000904	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GNAQ—melanoma	0.000412	0.000898	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PRKCA—melanoma	0.000406	0.000885	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KISS1—melanoma	0.000404	0.000879	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GAB2—melanoma	0.000403	0.000877	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GNA11—melanoma	0.000403	0.000877	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000401	0.000875	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MAP2K2—melanoma	0.000397	0.000866	CbGpPWpGaD
Goserelin—Hypersensitivity—Docetaxel—melanoma	0.000397	0.000733	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—melanoma	0.000396	0.000864	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—melanoma	0.000396	0.000863	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SKI—melanoma	0.000391	0.000852	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCR1—melanoma	0.000391	0.000852	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—F2R—melanoma	0.000389	0.000847	CbGpPWpGaD
Goserelin—Asthenia—Docetaxel—melanoma	0.000386	0.000714	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—MC1R—melanoma	0.000385	0.000839	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—PIK3CA—melanoma	0.000385	0.000838	CbGpPWpGaD
Goserelin—Pruritus—Docetaxel—melanoma	0.000381	0.000704	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—AKT3—melanoma	0.00038	0.000829	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCR4—melanoma	0.000379	0.000825	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—RAC1—melanoma	0.000377	0.000821	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EDNRB—melanoma	0.000376	0.00082	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GNAQ—melanoma	0.000374	0.000816	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	0.000374	0.000816	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GRM1—melanoma	0.000369	0.000804	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR7—melanoma	0.000369	0.000804	CbGpPWpGaD
Goserelin—Diarrhoea—Docetaxel—melanoma	0.000368	0.000681	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—PTK2B—melanoma	0.000365	0.000796	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SUFU—melanoma	0.00036	0.000784	CbGpPWpGaD
Goserelin—Dizziness—Docetaxel—melanoma	0.000356	0.000658	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—GAB2—melanoma	0.000355	0.000774	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GNA11—melanoma	0.000355	0.000774	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FLT1—melanoma	0.000354	0.000771	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CG—melanoma	0.00035	0.000764	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT3—melanoma	0.000345	0.000753	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	0.000344	0.000749	CbGpPWpGaD
Goserelin—Vomiting—Docetaxel—melanoma	0.000342	0.000633	CcSEcCtD
Goserelin—Rash—Docetaxel—melanoma	0.000339	0.000627	CcSEcCtD
Goserelin—Dermatitis—Docetaxel—melanoma	0.000339	0.000627	CcSEcCtD
Goserelin—Headache—Docetaxel—melanoma	0.000337	0.000623	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—RHOB—melanoma	0.000336	0.000732	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BCL2L11—melanoma	0.000336	0.000732	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCR4—melanoma	0.000334	0.000728	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HDAC2—melanoma	0.000334	0.000728	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FOXO4—melanoma	0.000334	0.000728	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GNAQ—melanoma	0.00033	0.00072	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HDAC6—melanoma	0.000323	0.000703	CbGpPWpGaD
Goserelin—Nausea—Docetaxel—melanoma	0.00032	0.000591	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—EDN1—melanoma	0.00032	0.000697	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CG—melanoma	0.000318	0.000693	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	0.000318	0.000693	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CSF2—melanoma	0.000312	0.000681	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SYK—melanoma	0.000311	0.000677	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CD—melanoma	0.000308	0.000671	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCR2—melanoma	0.000306	0.000667	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL8—melanoma	0.000306	0.000666	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ITGAV—melanoma	0.000305	0.000664	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NGFR—melanoma	0.000305	0.000664	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT3—melanoma	0.000305	0.000664	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	0.000305	0.000664	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RAC2—melanoma	0.000301	0.000656	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PRKCA—melanoma	0.0003	0.000653	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—WNT5A—melanoma	0.000296	0.000646	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFC—melanoma	0.000296	0.000646	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EDN1—melanoma	0.00029	0.000633	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CSF2—melanoma	0.000284	0.000618	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SOCS1—melanoma	0.000282	0.000615	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MAP2K1—melanoma	0.000282	0.000614	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—S100B—melanoma	0.000282	0.000614	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CD—melanoma	0.00028	0.00061	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—RAC1—melanoma	0.000278	0.000605	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PRKCA—melanoma	0.000272	0.000593	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ERBB4—melanoma	0.000269	0.000587	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CB—melanoma	0.000269	0.000585	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN2B—melanoma	0.000267	0.000582	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MAP2K2—melanoma	0.000266	0.000579	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—F2R—melanoma	0.00026	0.000567	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CD86—melanoma	0.000258	0.000563	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCL8—melanoma	0.000258	0.000562	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EDN1—melanoma	0.000256	0.000558	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—RAC1—melanoma	0.000252	0.000549	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EDNRB—melanoma	0.000252	0.000549	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CSF2—melanoma	0.00025	0.000546	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FGF1—melanoma	0.00025	0.000546	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—IL2—melanoma	0.000247	0.000537	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—E2F1—melanoma	0.000245	0.000534	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTK2B—melanoma	0.000245	0.000533	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CB—melanoma	0.000244	0.000531	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PDGFRA—melanoma	0.000242	0.000528	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ITGB3—melanoma	0.00024	0.000523	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRKCA—melanoma	0.00024	0.000523	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GAB2—melanoma	0.000238	0.000518	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GNA11—melanoma	0.000238	0.000518	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FLT1—melanoma	0.000237	0.000516	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SPP1—melanoma	0.000235	0.000513	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAP2K2—melanoma	0.000235	0.000511	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CG—melanoma	0.000235	0.000511	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCL8—melanoma	0.000234	0.000511	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL2—melanoma	0.000224	0.000488	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCR4—melanoma	0.000224	0.000487	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HDAC2—melanoma	0.000224	0.000487	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FOXO4—melanoma	0.000224	0.000487	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TERT—melanoma	0.000223	0.000486	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RAC1—melanoma	0.000223	0.000485	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GNAQ—melanoma	0.000221	0.000482	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HIF1A—melanoma	0.000213	0.000465	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CG—melanoma	0.000213	0.000464	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SYK—melanoma	0.000208	0.000453	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CD—melanoma	0.000206	0.000449	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT3—melanoma	0.000204	0.000445	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NGFR—melanoma	0.000204	0.000445	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ITGAV—melanoma	0.000204	0.000445	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KDR—melanoma	0.000204	0.000445	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FN1—melanoma	0.000196	0.000428	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOTCH1—melanoma	0.000192	0.000419	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SOCS1—melanoma	0.000189	0.000412	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MAP2K1—melanoma	0.000189	0.000411	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—S100B—melanoma	0.000188	0.000411	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CD80—melanoma	0.000188	0.00041	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APC—melanoma	0.000188	0.00041	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CG—melanoma	0.000188	0.00041	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KIT—melanoma	0.000188	0.00041	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—NRAS—melanoma	0.000188	0.00041	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CD—melanoma	0.000187	0.000408	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EGF—melanoma	0.000186	0.000405	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ERBB4—melanoma	0.00018	0.000393	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MAPK3—melanoma	0.00018	0.000392	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CB—melanoma	0.00018	0.000392	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN2B—melanoma	0.000179	0.000389	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—BRAF—melanoma	0.000177	0.000385	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CD86—melanoma	0.000173	0.000377	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL8—melanoma	0.000173	0.000376	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF1—melanoma	0.000172	0.000375	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EDN1—melanoma	0.000171	0.000374	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MAPK1—melanoma	0.000171	0.000373	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—EGFR—melanoma	0.000171	0.000373	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CSF2—melanoma	0.000168	0.000365	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGF1—melanoma	0.000168	0.000365	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAP2K1—melanoma	0.000166	0.000363	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CD—melanoma	0.000165	0.00036	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IL2—melanoma	0.000165	0.00036	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—E2F1—melanoma	0.000164	0.000357	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PIK3CA—melanoma	0.000164	0.000357	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CB—melanoma	0.000163	0.000356	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PDGFRA—melanoma	0.000162	0.000354	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—KRAS—melanoma	0.000162	0.000353	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ITGB3—melanoma	0.000161	0.00035	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRKCA—melanoma	0.000161	0.00035	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—FGF2—melanoma	0.000158	0.000345	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SPP1—melanoma	0.000158	0.000343	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAP2K2—melanoma	0.000157	0.000342	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL8—melanoma	0.000157	0.000342	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL2—melanoma	0.00015	0.000327	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TERT—melanoma	0.000149	0.000326	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RAC1—melanoma	0.000149	0.000325	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PIK3CA—melanoma	0.000149	0.000324	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MDM2—melanoma	0.000148	0.000323	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—ERBB2—melanoma	0.000146	0.000318	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CB—melanoma	0.000144	0.000314	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HIF1A—melanoma	0.000143	0.000311	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL8—melanoma	0.000138	0.000302	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HRAS—melanoma	0.000138	0.0003	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KDR—melanoma	0.000137	0.000298	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN1B—melanoma	0.000135	0.000295	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT1—melanoma	0.000134	0.000291	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CASP3—melanoma	0.000132	0.000289	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL2—melanoma	0.000132	0.000288	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—melanoma	0.000132	0.000287	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FN1—melanoma	0.000132	0.000287	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCND1—melanoma	0.000129	0.000281	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOTCH1—melanoma	0.000129	0.00028	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CTNNB1—melanoma	0.000128	0.000278	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CD80—melanoma	0.000126	0.000275	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KIT—melanoma	0.000126	0.000274	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APC—melanoma	0.000126	0.000274	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CG—melanoma	0.000126	0.000274	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—NRAS—melanoma	0.000126	0.000274	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—melanoma	0.000125	0.000273	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN1A—melanoma	0.000125	0.000272	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTEN—melanoma	0.000124	0.000271	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGF—melanoma	0.000124	0.000271	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NFKB1—melanoma	0.000124	0.00027	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT1—melanoma	0.000121	0.000265	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MAPK3—melanoma	0.000121	0.000263	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—BRAF—melanoma	0.000118	0.000258	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1—melanoma	0.000115	0.000251	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MAPK1—melanoma	0.000115	0.00025	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—EGFR—melanoma	0.000115	0.00025	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—melanoma	0.000112	0.000245	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAP2K1—melanoma	0.000111	0.000243	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STAT3—melanoma	0.000111	0.000243	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NRAS—melanoma	0.000111	0.000242	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CD—melanoma	0.000111	0.000241	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PIK3CA—melanoma	0.00011	0.000239	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—KRAS—melanoma	0.000108	0.000236	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK3—melanoma	0.000106	0.000232	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—FGF2—melanoma	0.000106	0.000231	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MYC—melanoma	0.000103	0.000225	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK1—melanoma	0.000101	0.000221	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EGFR—melanoma	0.000101	0.00022	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PIK3CA—melanoma	9.95e-05	0.000217	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MDM2—melanoma	9.91e-05	0.000216	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—ERBB2—melanoma	9.77e-05	0.000213	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CB—melanoma	9.64e-05	0.00021	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—KRAS—melanoma	9.56e-05	0.000208	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL8—melanoma	9.27e-05	0.000202	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HRAS—melanoma	9.21e-05	0.000201	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN1B—melanoma	9.05e-05	0.000197	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT1—melanoma	8.95e-05	0.000195	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CASP3—melanoma	8.87e-05	0.000193	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL2—melanoma	8.86e-05	0.000193	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—melanoma	8.81e-05	0.000192	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PIK3CA—melanoma	8.78e-05	0.000191	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCND1—melanoma	8.63e-05	0.000188	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CTNNB1—melanoma	8.55e-05	0.000186	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TP53—melanoma	8.5e-05	0.000185	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—melanoma	8.38e-05	0.000183	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN1A—melanoma	8.35e-05	0.000182	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTEN—melanoma	8.33e-05	0.000182	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NFKB1—melanoma	8.29e-05	0.000181	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT1—melanoma	8.13e-05	0.000177	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HRAS—melanoma	8.12e-05	0.000177	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—melanoma	7.78e-05	0.000169	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—melanoma	7.53e-05	0.000164	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STAT3—melanoma	7.45e-05	0.000162	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NRAS—melanoma	7.43e-05	0.000162	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT1—melanoma	7.17e-05	0.000156	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK3—melanoma	7.12e-05	0.000155	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—melanoma	6.93e-05	0.000151	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK1—melanoma	6.77e-05	0.000148	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EGFR—melanoma	6.77e-05	0.000148	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—KRAS—melanoma	6.4e-05	0.000139	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PIK3CA—melanoma	5.88e-05	0.000128	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TP53—melanoma	5.69e-05	0.000124	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HRAS—melanoma	5.44e-05	0.000119	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—melanoma	5.21e-05	0.000113	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT1—melanoma	4.8e-05	0.000105	CbGpPWpGaD
